The document discusses how XMPro devices can remotely monitor and control connected devices and sensors as part of the Internet of Things. It provides examples of how this capability could benefit industries like healthcare, infrastructure, and manufacturing. Specifically, it describes how XMPro's monitoring and response system could help healthcare providers and payers identify at-risk patients with chronic respiratory conditions, organize interventions, and ultimately reduce costs while improving health outcomes.

1.
XMIOT
monitoring Devices to processes
To Connect
50 Billion Devices by 2016
The Internet of “business things” Brings new challenges & Opportunities
• Provide Operational Intelligence
• Integrate Process with devices
• Monitor & control device remotely
• Gain Competitive Advantage
• Create new revenue streams
• Improve Asset Utilization
Some Use Cases for
“Internet of Business Things”
See www.xmpro.com/iot_UseCases
For more examples
Smart health
Smart Infrastructure
Smart Industry
XMPro Device Monitor
Connect Smart Devices & Sensors to Event-based Business Processes
Download our “HOW TO CONNECT YOUR BUSINESS TO THE INTERNET OF
THINGS” whitepaper from www.xmpro.com/info/internet-of-things
www.xmpro.com

2. XMPro ERAS
Event Response & Advisory system – Connect & Control from XMPro portal
The Smart Sensor above monitors
air quality for smart cities.
See www.xmpro.com/iot_UseCases
For more examples
The XMPro screen example above right illustrates the practical implementation of the
monitoring and response system shown in the XMPro DeviceMonitor diagram on
previous page. It shows how a device triggered an XMPro process based on a
temperature alert and in addition to managing an intervention process or workflow,
engineers, doctors and service staff can, for example, access the device remotely
from with their XMPro work portal and make adjustments as necessary.
• View Multiple sensors on 1 screen
• Access & control device remotely
• Offer new services to customers
Smart health use case
If We can do this then Just Imagine what it can do for your business
Chronic Obstructive Pulmonary Disease (COPD) is estimated to cost $29.5 billion in direct healthcare
costs annually in the United States and is the 4th leading cause of death. Asthma is estimated to affect
1 in 12 Americans with 1 in 2 of those having preventable asthma attacks.
Both COPD and Asthma are chronic diseases and patient involvement in the management of the
disease has a large impact on the likelihood of complications, unplanned hospital admissions,
additional procedures and the patient's quality of life.
One of the most effective preventions for these respiratory diseases is the use of medication to control
symptoms. The challenge however is ensuring that patients are using the prescribed medications
since less than 50% of patients take medications as prescribed. It has been shown that increasing
medication adherence results in better health outcomes for patients while reducing the overall spend
to achieve these outcomes.
Smartinhaler enables home monitoring of COPD and Asthma medications and records the type of medication taken, when it was taken
and measures the overall medication adherence. When combined with the ability of XMPro to provide alerts and tasks that can be
triggered enables Healthcare Payers and service providers to quickly identify patients who need the most support with their medications
and conditions, to organize appropriate pro-active treatment and intervention and thereby prevent expensive hospital visits and
procedures for emergency conditions.
Smartinhaler can identify at risk patients through indications such as low adherence to preventor medications and increased use of
reliever medications. Using XMPro to provide alerts and create case management tasks will enable Healthcare Payers and service
providers to quickly identify members who are at risk and provide appropriate intervention services.
Using XMPro longer term to combine the information from Smartinhaler with data sources that Healthcare Payers and service providers
may have on members, such as previous unplanned admissions, co-morbidities or even the frequency of prescription refills, will enable
Healthcare Payers and service providers to more accurately predict those members who may benefit from additional interventions. The
interventions are based on the member profiles that would be built up over time.
The provision of this type of intervention will result in lower overall healthcare costs and improved health outcomes for members through
the use of data based interventions.
See www.smartinhaler.com for more information on SmartInhaler devices and solutions.
North America
10000 North Central Expressway,
Suite 400, Dallas, TX 75231
P (+1) 214 890 4093
Asia Pacific
16/124 Walker Street
North Sydney, 2060
P +61 (0) 2 8412 1000
UK & Europe
Gartner does not endorse any vendor; product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest
ratings. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties,
expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
8345353836456056
Africa
5/201 Great Portland St
London, W1W5AB
P +44 (0) 207 268 9810
A/17 Muswell Rd South
Bryanston, Johannesburg
P +27 (0) 11 540 0250